1. Home > Latest Topics >

Question 13: Outcome measures for AECB clinical trials

20 June, 2018

question_13_6


LATEST TOPICS

Navigating antibiotic resistance in community-acquired pneumonia: Insights from Vietnam
29 October, 2024
Optimising antibiotic therapy: Insights on transitioning from intravenous to oral treatment for community-acquired pneumonia
27 September, 2024
Community-acquired pneumonia in Cambodia: Navigating the growing challenge of AMR
30 June, 2024
Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024

RELATED ARTICLES

Standardized treatment of chronic obstructive pulmonary disease (COPD)
17 January, 2023
What Can We Do in the Face of the Mycoplasma Pneumonia Epidemic?
11 January, 2024
Under the new medical reform, there are challenges for the rational use of antibiotics, making it necessary to adopt coping strategies
20 April, 2023
Emergence of Mycoplasma Pneumoniae Pneumonia: Key Considerations in Diagnosis and Medication Strategies
26 January, 2024
New Developments in Infection Control in China
06 May, 2022